S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
How to Invest in AI's Fast-Growing Market (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
How to Invest in AI's Fast-Growing Market (Ad)
Canada Goose is Projecting Optimism, but Investors Aren’t Buying
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
Is Graphite the New Lithium? (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
How to Invest in AI's Fast-Growing Market (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
How to Invest in AI's Fast-Growing Market (Ad)
Canada Goose is Projecting Optimism, but Investors Aren’t Buying
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
Is Graphite the New Lithium? (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
How to Invest in AI's Fast-Growing Market (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
How to Invest in AI's Fast-Growing Market (Ad)
Canada Goose is Projecting Optimism, but Investors Aren’t Buying
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
Is Graphite the New Lithium? (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
10 Ways Entrepreneurs Can Navigate a Down Economy
How to Invest in AI's Fast-Growing Market (Ad)
Did SOFI Technologies Deserve a Price Target Cut to $2.50?
Get the Most Out of Remote Meetings and Avoid Meeting Burn Out
How to Invest in AI's Fast-Growing Market (Ad)
Canada Goose is Projecting Optimism, but Investors Aren’t Buying
A Woman Co-founder's Guide to Empowering Women in the Workplace and Advocating for Gender Equality
Is Graphite the New Lithium? (Ad)
Open vs. Anonymous Employee Feedback — Which is Better?
Stock market today: Global shares mixed as investors await debt ceiling vote, eye China economy
OTCMKTS:PHMMF

Pharma Mar (PHMMF) News Today

$41.21
0.00 (0.00%)
(As of 05/26/2023)
Compare
Today's Range
$41.21
$41.21
50-Day Range
$41.21
$69.40
52-Week Range
$41.21
$79.38
Volume
13 shs
Average Volume
29 shs
Market Capitalization
$742.10 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Pharma Mar News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter.



PHMMF Media Mentions By Week

PHMMF Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

PHMMF
News Sentiment

0.00

0.78

Average
Medical
News Sentiment

PHMMF News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

PHMMF Articles
This Week

0

0

PHMMF Articles
Average Week

SourceHeadline
msn.com logoNEEDHAM & COMPANY INC. Maintains Pharma Mar (XMAD:PHM) Buy Recommendation
msn.com - April 22 at 8:50 AM
MarketBeat logoPharma Mar (OTCMKTS:PHMMF) Hits New 12-Month Low at $47.70
americanbankingnews.com - March 29 at 7:00 AM
marketwatch.com logoPharmaceutical Excipients Market Top Players By 2031
marketwatch.com - March 27 at 8:51 AM
news.yahoo.com logoPharmaceutical company to open in McHenry
news.yahoo.com - March 25 at 8:48 AM
markets.businessinsider.com logoInnate Pharma (IPHA) Receives a Buy from H.C. Wainwright
markets.businessinsider.com - March 24 at 7:39 AM
bizjournals.com logoBig Pharma companies back new startup out of Mass General Brigham
bizjournals.com - March 16 at 8:33 PM
markets.businessinsider.com logoPiramal Pharma Limited Announces Consolidated Results for Q2 and H1 FY2023
markets.businessinsider.com - November 9 at 2:50 AM
yahoo.com logoEuropean Commission suspects pharma group Teva broke antitrust rules
yahoo.com - October 10 at 5:51 AM
apnews.com logoPharmacists Database List of Emails, Phone Numbers, Contact Information
apnews.com - August 30 at 2:21 AM
finance.yahoo.com logoLife Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants
finance.yahoo.com - January 11 at 12:42 PM
finanznachrichten.de logoPharmaMar signs a licensing and commercialization agreement with Lotus Pharmaceutical for lurbinectedin in Taiwan
finanznachrichten.de - November 11 at 11:23 AM
news.yahoo.com logoSpain's PharmaMar posts 58% drop in 9-mth profit despite higher revenues
news.yahoo.com - October 28 at 5:34 PM
reuters.com logoSpain's PharmaMar nine-month net profit falls 58%
reuters.com - October 28 at 12:32 PM
nasdaq.com logoSpain's PharmaMar sales rise on demand for cancer treatments
nasdaq.com - July 29 at 2:35 PM
reuters.com logoSpain's PharmaMar says COVID-19 treatment shows clinical efficacy in trials
reuters.com - May 26 at 7:19 AM
investing.com logoPharma Mar SAU (PHMR)
investing.com - April 30 at 1:20 PM
reuters.com logoSpain's regulator lets PharmaMar test treatment on COVID-19 patients
reuters.com - April 29 at 3:32 PM
cn.reuters.com logoUPDATE 2-PharmaMar soars 21% after journal Science confirms drug's efficacy against COVID
cn.reuters.com - January 27 at 7:52 AM
reuters.com logoScience Magazine confirms efficacy of PharmaMar's Plitidepsin against COVID-19
reuters.com - January 26 at 2:45 PM
reuters.com logoUPDATE 1-PharmaMar says paper in journal Science confirms vaccine efficacy
reuters.com - January 26 at 9:44 AM
markets.businessinsider.com logoPharma Mar SA Bearer Shs Stock , PHMMF
markets.businessinsider.com - December 28 at 11:12 PM
nasdaq.com logoAmicus Therapeutics (FOLD) Catches Eye: Stock Jumps 8.1%
nasdaq.com - December 15 at 12:36 PM
msn.com logoCambio en el Ibex: PharmaMar ocupará el puesto de Ence el 21 de septiembre
msn.com - September 11 at 3:14 AM
finance.yahoo.com logoPharma Mar, S.A. (PHMMF)
finance.yahoo.com - May 26 at 7:34 PM
finance.yahoo.com logoPharmaMar Has Announced That the Spanish Medicines Agency Has Authorized the APLICOV-PC Clinical Trial With Aplidin® (Plitidepsin) for the Treatment of Patients With COVID-19
finance.yahoo.com - April 28 at 7:37 AM
finance.yahoo.com logoThe Pharma Mar (BME:PHM) Share Price Is Up 157% And Shareholders Are Boasting About It
finance.yahoo.com - March 21 at 8:39 AM
www.lse.co.uk logoSpain's PharmaMar receives CE approval for coronavirus diagnostic kits
www.lse.co.uk - March 6 at 2:05 PM
uk.reuters.com logoPharmaMar shares jump after coronavirus diagnosis kit gets EU certification
uk.reuters.com - March 6 at 9:04 AM
seekingalpha.com logoFDA accepts PharmaMar's lurbinectedin application for lung cancer
seekingalpha.com - February 18 at 9:07 AM
www.benzinga.com logoPharmaMar and Jazz Pharmaceuticals Announce FDA...
www.benzinga.com - February 17 at 7:42 AM
finance.yahoo.com logoAnalysts Expect Breakeven For Pharma Mar, S.A. (BME:PHM)
finance.yahoo.com - January 21 at 7:22 AM
finance.yahoo.com logoAre Insiders Buying Pharma Mar, S.A. (BME:PHM) Stock?
finance.yahoo.com - December 6 at 9:04 AM
finance.yahoo.com logoDoes Pharma Mar, S.A. (BME:PHM) Have A High Beta?
finance.yahoo.com - October 1 at 8:43 AM
finance.yahoo.com logoPharma Mar (BME:PHM) Is Making Moderate Use Of Debt
finance.yahoo.com - August 29 at 6:24 PM
www.businesswire.com logoGlobal Dermal Filler Medical Devices Pipeline Assessment 2019: Products Under Development, Companies & Products, and Recent Developments - ResearchAndMarkets.com - Business Wire
www.businesswire.com - February 25 at 6:10 PM
Get Pharma Mar News Delivered to You Automatically

Sign up to receive the latest news and ratings for PHMMF and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:PHMMF) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -